In the case of DYT1 dystonia patients, L-dopa is not therapeutic, suggesting that dopamine cannot compensate for defects resulting from mutant torsinA (Breakefield et al., 2008). This evidence concerns the gene TOR1A and early-onset generalized limb-onset dystonia.